conclusions development of novel drugs and diagnostic tests has allowed us to better manage vl. although leishmaniasis is one of the oldest known parasitic infectious diseases, increasing prevalence of vl among specific populations, recent reports of disease reactivation and flare-up in clinically asymptomatic patients after the onset of immunosuppressive therapy, the risk of disease acquisitio...